Polymorphonuclear cell-mediated phagocytosis and superoxide anion release in insulin-dependent diabetes mellitus

Cytobios. 1993;74(298-299):189-95.

Abstract

It is well known that patients with insulin-dependent (or type I) diabetes mellitus are at high risk for bacterial infections. Since conflicting results have been reported on non-specific immune responses in type I diabetes, polymorphonuclear cell (PMN)-mediated phagocytosis and superoxide anion (O2-) generation in a group of individuals with well-controlled type I diabetes mellitus were assessed. Results showed that diabetic subjects were characterized by a significant impairment of phagocytic capacity when compared with healthy donors, while O2- release mimicked that seen in controls. Cell pretreatment with beta-hydroxybutyric acid (beta-HB) gave rise to a significant reduction in either phagocytosis or O2- production by PMN from type I diabetic individuals. Finally, beta-HB and glucose mixture supplementation to PMN suspensions did not induce any modification of their functional activities in comparison with those exerted by cells treated with beta-HB only. A disease-related or beta-HB-mediated PMN dysfunction in insulin-dependent diabetes mellitus is indicated.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Hydroxybutyric Acid
  • Adolescent
  • Adult
  • Candida albicans
  • Cells, Cultured
  • Diabetes Mellitus, Type 1 / complications
  • Diabetes Mellitus, Type 1 / physiopathology*
  • Glucose / pharmacology
  • Humans
  • Hydroxybutyrates / pharmacology
  • Neutrophils / drug effects
  • Neutrophils / physiology*
  • Phagocytosis / drug effects
  • Phagocytosis / physiology*
  • Respiratory Burst / drug effects
  • Respiratory Burst / physiology
  • Superoxides / metabolism*

Substances

  • Hydroxybutyrates
  • Superoxides
  • Glucose
  • 3-Hydroxybutyric Acid